CClinicalTrials.gg
Not yet recruitingNCT07323459Updated Jan 7, 2026

A Midwife-Led Psychoeducational Intervention to Reduce Pregnancy-Related Anxiety in Low-Risk Pregnant Women

An interventional study of A Midwife-Led Psychoeducational Intervention to Reduce Pregnancy-Related Anxiety in Low-Risk Pregnant Women in Pregnancy-Related Anxiety (PrA) and Fear of Childbirth, sponsored by Medical University of Gdansk. Not yet recruiting at 1 site in Poland. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-07.

Sponsored by Medical University of Gdansk · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of this clinical trial is to evaluate whether an individualized psychoeducational intervention led by an experienced midwife can reduce pregnancy-related anxiety (PrA) in pregnant women during the second and third trimesters. The main questions it aims to answer are:

  • Can individualized midwife-led psychoeducation significantly reduce pregnancy-related anxiety levels as measured by the PRAQ-R2 questionnaire?
  • Does this intervention improve women's sense of control, competence, and readiness for childbirth?
  • Can the intervention reduce preferences for cesarean section without medical indication among low-risk pregnant women?

Participants will:

  • Attend 4-6 individual sessions (approximately 60 minutes each) with a midwife, scheduled every 1-2 weeks
  • Complete the Pregnancy-Related Anxiety Questionnaire (PRAQ-R2) at the beginning and end of the intervention to measure anxiety levels
  • Receive evidence-based education about the physiological process of childbirth, pain management methods (both pharmacological and non-pharmacological), and medical procedures
  • Learn and practice stress-reduction techniques including breathing exercises, relaxation methods, and mindfulness
  • Develop an individualized birth plan and practice communication skills for effective interaction with medical personnel
  • Work on cognitive strategies to address negative thoughts and build positive affirmations about childbirth
02

Conditions studied

  • Pregnancy-Related Anxiety (PrA)
  • Fear of Childbirth

Browse trials for

Keywords

  • prenatal care
  • pregnancy-related anxiety
  • maternal mental health
  • anxiety
  • pregnancy
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's planned enrollment of 80 is close to the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Medical University of Gdansk is the lead sponsor of 130 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Pregnant women in the second or third trimester of pregnancy
  • Elevated level of pregnancy-related anxiety (PrA)
  • Low obstetric risk pregnant women (no significant medical contraindications to vaginal delivery)
  • Consent to participate in individual psychoeducational sessions
  • Ability to communicate in Polish at a level sufficient to understand the materials and participate in the sessions

Exclusion criteria

Exclusion Criteria:

  • Pregnant women with severe mental disorders requiring urgent psychiatric intervention
  • Women with serious obstetric complications in the current pregnancy requiring intensive medical monitoring (e.g., severe hypertension, imminent preterm delivery requiring hospitalization)
  • Patients already undergoing intensive psychotherapy or pharmacotherapy for anxiety
  • Lack of consent to participate or inability to attend sessions (e.g., due to logistical reasons)
  • Pregnant women whose pregnancy-related anxiety is not the primary concern, with other dominant anxiety disorders (e.g., GAD unrelated to pregnancy) or other priority health needs
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Pregnant women with high PrA levels receiving midwife-led individual psychoeducational intervention

    Other: A Midwife-Led Psychoeducational Intervention to Reduce Pregnancy-Related Anxiety in Low-Risk Pregnant Women

  • No intervention
    Standard prenatal care without additional psychoeducational intervention

Interventions

  • OtherA Midwife-Led Psychoeducational Intervention to Reduce Pregnancy-Related Anxiety in Low-Risk Pregnant Women

    Individual program by midwife in 2nd/3rd trimester: 4-6 sessions (\~60min), every 1-2 weeks. Session 1: PRAQ-R2 assessment, identifying fears, building trust. Session 2: Labor stages education, myth verification, visual aids. For multiparous: previous birth discussion. Session 3: Pain management - breathing, relaxation, massage, hydrotherapy, epidural, nitrous oxide. Practical exercises. Session 4: Birth plan development, assertive communication training, role-playing. Session 5: Mindfulness, cognitive restructuring, affirmations, visualization, final PRAQ-R2. Session 6 (optional): Techniques review, birth plan finalization, Q\&A, contact plan. Materials: brochures, diagrams, videos, templates, audio instructions. Flexible, individualized.

06

What researchers measure

Primary outcomes

  1. Pregnancy-Related Anxiety Level

    Measure: Change in Pregnancy-Related Anxiety Questionnaire-Revised 2 (PRAQ-R2) total score from baseline to post-intervention. Description: The PRAQ-R2 is a validated 10-item questionnaire assessing pregnancy-specific anxiety, using a 5-point Likert scale. Total scores range from 10 to 50, with higher scores indicating higher levels of pregnancy-related anxiety (worse outcome). The Polish validated version of the questionnaire will be used. A decrease in score reflects a reduction in anxiety.

    Time frame: Baseline (Session 1, before intervention start) and post-intervention (after completing 4-6 sessions, approximately 8-12 weeks from baseline)

07

Study locations

1 site
  • Division of Obstetric and Gynaecological Nursing, Faculty of Health Sciences with the Institute of Maritime and Tropical Medicine, Medical University of Gdańsk
    Gdansk, 80-210, Poland
08

References and documents

Publications

  • Krawczyk A, Czerwinska-Osipiak A, Wojcicka L, Michalik A, Gruszecka A. Study protocol for a midwife-led psychoeducational intervention to reduce pregnancy-related anxiety in low-risk pregnant women. Front Public Health. 2026 Jun 3;14:1832201. doi: 10.3389/fpubh.2026.1832201. eCollection 2026. PubMed 42317977 ↗

Individual participant data

Plan to share: No — IPD will not be shared to protect participant confidentiality and due to data protection regulations. Results will be published in aggregated form.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07323459
Lead sponsor
Medical University of Gdansk
Responsible party
Sponsor
First posted
Jan 7, 2026
Start date
Jan 1, 2026 (estimated)
Primary completion
Feb 28, 2028 (estimated)
Completion
Feb 28, 2028 (estimated)
Last update
Jan 7, 2026

Study contacts

Aleksandra Krawczyk
Contact
a.krawczyk@gumed.edu.pl
+48 539 707 706

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion